1. Home
  2. OTLY vs CDXS Comparison

OTLY vs CDXS Comparison

Compare OTLY & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OTLY
  • CDXS
  • Stock Information
  • Founded
  • OTLY 1994
  • CDXS 2002
  • Country
  • OTLY Sweden
  • CDXS United States
  • Employees
  • OTLY N/A
  • CDXS N/A
  • Industry
  • OTLY Packaged Foods
  • CDXS Major Chemicals
  • Sector
  • OTLY Consumer Staples
  • CDXS Industrials
  • Exchange
  • OTLY Nasdaq
  • CDXS Nasdaq
  • Market Cap
  • OTLY 395.7M
  • CDXS 332.0M
  • IPO Year
  • OTLY 2021
  • CDXS 2010
  • Fundamental
  • Price
  • OTLY $0.69
  • CDXS $5.00
  • Analyst Decision
  • OTLY Buy
  • CDXS Buy
  • Analyst Count
  • OTLY 3
  • CDXS 2
  • Target Price
  • OTLY $1.27
  • CDXS $11.00
  • AVG Volume (30 Days)
  • OTLY 2.9M
  • CDXS 782.6K
  • Earning Date
  • OTLY 02-12-2025
  • CDXS 02-26-2025
  • Dividend Yield
  • OTLY N/A
  • CDXS N/A
  • EPS Growth
  • OTLY N/A
  • CDXS N/A
  • EPS
  • OTLY N/A
  • CDXS N/A
  • Revenue
  • OTLY $813,471,000.00
  • CDXS $64,446,000.00
  • Revenue This Year
  • OTLY $7.92
  • CDXS N/A
  • Revenue Next Year
  • OTLY $6.69
  • CDXS $2.02
  • P/E Ratio
  • OTLY N/A
  • CDXS N/A
  • Revenue Growth
  • OTLY 5.06
  • CDXS N/A
  • 52 Week Low
  • OTLY $0.60
  • CDXS $2.53
  • 52 Week High
  • OTLY $1.40
  • CDXS $6.08
  • Technical
  • Relative Strength Index (RSI)
  • OTLY 53.12
  • CDXS 53.10
  • Support Level
  • OTLY $0.65
  • CDXS $4.24
  • Resistance Level
  • OTLY $0.69
  • CDXS $5.51
  • Average True Range (ATR)
  • OTLY 0.05
  • CDXS 0.33
  • MACD
  • OTLY 0.00
  • CDXS -0.03
  • Stochastic Oscillator
  • OTLY 49.39
  • CDXS 59.84

About OTLY Oatly Group AB

Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.

About CDXS Codexis Inc.

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.

Share on Social Networks: